New York, NY -- (SBWIRE) -- 07/15/2015 -- The "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)" is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Republic of China (Taiwan). Taiwan's population increased slightly between 2008 and 2013 from 23.0 to 23.4 million, mainly due to a rising life expectancy. However, the birth rate decreased at a negative Compound Annual Growth Rate (CAGR) of 0.2%. The pharmaceutical market was estimated at $5.4 billion in 2013 and is projected to reach $8.4 billion by 2020 at a CAGR of 6.4%. The medical device market was worth $2.2 billion in 2013 and is projected to reach $3.1 billion by 2020 at a CAGR of 5.3%, primarily attributed to an increasingly elderly population, and universal healthcare coverage. Government initiatives, such as a reduction in income tax for new pharmaceutical companies that establish themselves in Taiwan, are intended to encourage foreign companies to invest and will further boost the market.

Get a complete report on "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)" @ https://wiseguyreports.com/reports/countryfocus-healthcare-regulatory-and-reimbursement-landscape-republic-of-china-taiwan-one

The report identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

The report provides information on the healthcare, regulatory, and reimbursement landscape in Taiwan, and includes -

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi, GlaxoSmithKline, Yung Shin Pharmaceutical, and China Chemical & Pharmaceutical; and of major players in the medical device market: Baxter International, Fresenius Medical Care, Siemens Healthcare, GE Healthcare, and China Chemical & Pharmaceutical

- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices

- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Taiwanese healthcare market

Inquire more about this report@ https://wiseguyreports.com/enquiry/countryfocus-healthcare-regulatory-and-reimbursement-landscape-republic-of-china-taiwan-one

This report will enhance your decision-making capability by allowing you to -

- Develop business strategies by understanding the trends shaping and driving Taiwan's healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Taiwan's healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in Taiwan's healthcare market

Get a discount on this report @ https://wiseguyreports.com/check_discount/countryfocus-healthcare-regulatory-and-reimbursement-landscape-republic-of-china-taiwan-one

Major Points in Table of Contents

Table of Contents

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 13
2 Introduction 18
2.1 GlobalData Report Guidance 18
3 Overview of Pharmaceutical and Medical Device Markets 19
3.1 Pharmaceutical Market 19
3.1.1 Market Overview 19
3.1.2 Pharmaceutical Exports and Imports 23
3.1.3 Supply Channels 24
3.1.4 Market Segments 24
3.1.5 Overview of Top Five Disease Areas 27
3.1.6 Major Players 30
3.2 Medical Device Market 63
3.2.1 Market Overview 63
3.2.2 Overview of Top Five Segments 65
3.2.3 Diagnostic market 76
3.2.4 Major Players 77
3.3 Market Drivers and Barriers 107
3.3.1 Drivers 107
3.3.2 Barriers 108
4 Market Access 110
4.1 Reimbursement and Payer Landscape 110
4.1.1 Overview of Healthcare System 110
4.1.2 Reimbursement Process 113
4.1.3 Overview of Insurance Providers 116
4.1.4 Patient Share in Healthcare Spending 120
4.1.5 Price Trend in Healthcare Services 121
4.1.6 Pricing Policies 123
4.2 Regulatory Landscape 124
4.2.1 Overview of Regulatory Agencies 124
4.2.2 Market Authorization Procedure for Pharmaceutical Products 126
4.2.3 Market Authorization Procedure for Medical Devices 130
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 133
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 136
4.2.6 Intellectual Property Rights 137
4.2.7 Clinical Trial Regulations 140
4.2.8 Pharmaceutical Advertising Regulations 141
4.2.9 Pharmacy Regulations 142
4.2.10 Labeling and Packaging Regulations 143
5 Country Analysis 144
5.1 Political Environment 144
5.1.1 Political Structure 144
5.1.2 Analysis of the Current Political Environment 145
5.1.3 Healthcare Policy Initiatives 146
5.2 Economic Landscape 148
5.3 Economic Indicators 149
5.3.1 Gross Domestic Product 149
5.3.2 National Income per Capita 153
5.3.3 Inflation 154
5.3.4 Currency Exchange Rate 158
5.3.5 Foreign Direct Investment 159
5.3.6 Foreign Exchange Reserves 160
5.3.7 Trade Balance 162
5.3.8 Government Structural Balance 164
5.3.9 General Government Gross Debt 166
5.3.10 Major Industries 168
5.4 Demographics 169
5.4.1 Population 169
5.4.2 Education and Literacy 185
5.4.3 Employment 186
5.4.4 Disease Burden 189
5.5 Healthcare Infrastructure 190
5.5.1 Healthcare Facilities 190
5.5.2 Healthcare Parameters 201
5.5.3 Environmental Health 203
5.5.4 Healthcare Personnel 206
5.6 Healthcare Expenditure 210
5.6.1 Overview 210
5.6.2 Major Components of Healthcare Spending 211
5.6.3 Public and Private Sector Share 213
5.6.4 Spending in Pharmaceutical Research and Development 215
5.7 Trade Associations 216
5.7.1 Taiwan Medical and Biotech Industry Association 216
5.7.2 Taiwan Public Health Association 216
5.7.3 Taiwan Medical Association 216
5.7.4 Taiwan Generic Pharmaceutical Association 216
5.8 Trade Fairs 217
6 Opportunities and Challenges 218
6.1 Opportunities 218
6.2 Challenges 219
7 Appendix 221
7.1 Abbreviations 221
7.2 Bibliography 225
7.3 Research Methodology 238
7.3.1 Coverage 238
7.3.2 Secondary Research 239
7.3.3 Forecasts 239
7.3.4 Expert Panel 239
7.4 Disclaimer 240

About Wise Guy Reports
Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Contact:
Norah Trent
646-845-9349 (US)
+44 208 133 9349 (UK)
sales@wiseguyreports.com

Connect with US:
G+ / Google Plus: https://plus.google.com/100535494506775102718
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/pages/WiseGuy-Research-Consultants-Pvt-Ltd/1509220196008846